LifeStance Health Group, Inc. Announces Results of 2026 Annual Meeting of Stockholders

LifeStance Health Group, Inc. (NASDAQ: LFST) has released the results of its Annual Meeting of Stockholders held on June 2, 2026. The meeting covered several key proposals, the outcomes of which may be important for shareholders and could influence the company’s share price.

Key Highlights from the Annual Meeting

• Election of Directors:
  • Two directors, David Bourdon and Robert Bessler, were elected to serve as Class II Directors for a three-year term.
  • Voting Results for Directors:
    • David Bourdon:
      • Votes For: 244,968,319
      • Votes Withheld: 83,966,052
      • Broker Non-Votes: 29,782,714
    • Robert Bessler:
      • Votes For: 280,015,618
      • Votes Withheld: 48,918,753
      • Broker Non-Votes: 29,782,714
  • Shareholder Impact: The significant number of withheld votes (especially for Mr. Bourdon) may signal some investor dissatisfaction, which is important for shareholders to note. Such voting patterns can sometimes precede future governance or management changes that may move the share price.
• Ratification of Independent Registered Public Accounting Firm:
  • PricewaterhouseCoopers LLP was ratified as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  • Voting results:
    • For: 357,756,707
    • Against: 209,431
    • Abstain: 750,947
  • Shareholder Impact: The overwhelming support for PricewaterhouseCoopers LLP suggests broad shareholder confidence in the company’s financial oversight and audit practices, which is generally positive for investor sentiment.
• Advisory Vote on Named Executive Officer Compensation (“Say-on-Pay”):
  • Shareholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers.
    • For: 322,904,359
    • Against: 5,675,861
    • Abstain: 354,151
    • Broker Non-Votes: 29,782,714
  • Shareholder Impact: The strong approval of executive compensation indicates investor satisfaction with management’s performance, which could support share value stability in the near term.

Other Regulatory and Administrative Details

• The company is incorporated in Delaware (DE) and is registered under the SEC file number 001-40478.
• Its common stock, with a par value of \$0.01 per share, trades under the symbol LFST on the NASDAQ stock exchange.
• LifeStance Health Group, Inc. is not classified as an “emerging growth company” as defined by SEC regulations.
• No written communications, soliciting material, or pre-commencement tender offers were reported in this filing, which means no extraordinary corporate actions or M&A activity disclosures were made.

Potential Share Price Impact

• The election results and support for management and auditors are largely in line with expectations and suggest continued stability in governance and oversight.
• The sizable “withhold” votes for one director could be noteworthy if it reflects broader governance concerns; investors may want to monitor any follow-up actions by the board or activist shareholders.
• No material adverse or positive news or strategic shifts were disclosed that would likely move the share price significantly in the immediate term.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to review the full official filings and consult their financial advisors before making investment decisions related to LifeStance Health Group, Inc. The author does not hold any position in LFST at the time of writing.

View LifeStance Health Group, Inc. Historical chart here